Loading…

Globe LifeGLCompetitor analysis, valuation and peers

United States · USD·Financials›Multi-Line Insurance

US life and supplemental health insurer selling small policies to middle-income households mainly through captive agencies.

Momentum neutral 45
Mkt cap
$11.7B
US dollars, full cap
Free float
99%
of shares outstanding
$/day
$107M
20-day average traded
P/B
1.78×
price to book
ROE
19.3%
delivered
Implied ROE
10.8%
what the price asks
Official | Implied
A / BBB
agencies · bond market
Next earnings
84 days
10 Feb 2027
Close · USD$155.15
1D-1.8%
1W-4.1%
1M-8.6%
3M-9.0%
6M+0.5%
YTD+11.4%
1Y+18.6%
ATR %2.3%
Beta0.35
52w lowhigh19.0% off high

What Globe Life does

US life and supplemental health insurer selling small policies to middle-income households mainly through captive agencies.

Pays its own agents to sell small life and supplemental health policies, and also sells by direct mail and online. It earns premiums that are largely level for years and invests the float, so profit depends on claims experience and on how long policies stay in force.

Products and services

  • Individual life insurance
  • Supplemental health insurance
  • American Income/Liberty National agencies
  • Direct-to-consumer marketing

Customers

  • Middle/lower-income US households
  • Union/association members

Where it sits in the supply chain

  • Insurance
  • Life & supplemental health
  • Direct-response and exclusive-agency…

What could go right

  • Growing underinsured middle-market demand
  • Agency force expansion

What could go wrong

  • Agent-recruiting/short-seller scrutiny risk
  • Persistency and reserve assumption risk

Moat: narrow (distribution, cost advantage). Large captive agent force selling low face-value policies at low unit cost to an underserved segment.

Headquarters: McKinney, Texas, US · Founded: 1900 · Employees: 3,695

Named competitors

Globe Life at a glance

Size Globe Life (GL) is a United States Financials company (Multi-Line Insurance) with a market value of $11.7B, the 700th largest of 3,085 United States companies the cockpit tracks. Shares closed at $155.15 on 18 Nov 2026.

Performance Over six months the shares gained 0.5%, against +8.0% for the median peer and -2.2% for the United States market (cap-weighted) — 6th lowest of 21 in its peer set.

Growth Revenue grew 5.6% over the last twelve months (peer median +7.9%); the operating margin is 25.9% (peer median 16.5%).

Valuation It trades at 1.78× book value against a peer median of 1.52× (9th most expensive of 21).

Price implies The share price implies a return on equity of about 10.8%; Globe Life delivers 19.3%, so the price asks less than the business earns today.

Credit Globe Life has 4 bonds outstanding ($1.80B), rated A by the agencies and trading like BBB at a weighted spread of 99 bp.

Short interest Short interest is 3.0% of the free float (30 Oct 2026).

Next results Next results expected around 10 Feb 2027 (exchange calendar; dates can move).

Relative performance

10011012021 May 202621 Aug 202618 Nov 2026Peer median 108GL 99
Six months, rebased to 100: Globe Life against the median of its 20 peers (local-currency closes).

Globe Life financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$6.27B$5.99B$5.78B$5.45B$5.23B
Revenue growth—+4%+6%+4%—
Net income$1.19B$1.16B$1.07B$971M$894M
Free cash flow$1.33B$1.25B$1.33B$1.43B$1.39B
Capital expenditure$76.9M$142M$71.0M$49.6M$27.9M
Total debt$2.99B$2.63B$2.74B$2.12B$2.08B

Quarterly statements and history in the cockpit →

Globe Life competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%-10%0%+10%UNMABCAPITALAGNCNAMAPBNTGJFSUNKNSLPZULNCHSXASRNL0966AXSG070058301336RLILGENGL6-month return →1-month return →
Up and to the right = strong over both horizons. Globe Life is the large dot.

Fundamentals: return on equity against price-to-book

0%10%20%30%20×40×60×UNMABCAPITALAGNCNABNTGJFSUNKNSLPZULNCHSXASRNL0966AXS0058301336RLILGENGLReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Globe Life is the large dot.

Capital: ROE delivered against the ROE the price implies

0%10%20%30%40%0%20%40%UNMABCAPITALAGNCNABNTGJFSUNKNSLPZULNCHSX0966AXSG070058301336RLILGENGLROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. Globe Life is the large dot.

Globe Life competitors and peer comparison

Head to head with its named competitors (GL vs AFL vs UNM vs PRI)
CompanyMarket cap6M returnRevenue growthROEPrice / bookImplied ROE
Globe Life GL$11.7B0%+6%19%1.78×10.8%
Aflac AFL$62.0B+7%-6%12%2.12×13.2%
Unum UNM$11.8B-9%-4%2%1.11×7.0%
Primerica PRI$8.95B+5%+8%31%3.18×23.2%
Amplitude Energy AEL.AX$322M-3%+7%-6%0.96×9.3%
MetLife MET$62.7B+21%+15%20%2.83×19.9%

How Globe Life compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Globe Life against its 20 peers (data as of 18 Nov 2026)
MeasureGLPeer medianRank in peer set
1-month return-8.6%+4.0%3rd lowest of 21
6-month return+0.5%+8.0%6th lowest of 21
Return on equity19.3%16.3%9th highest of 21
Price / book1.78×1.52×9th most expensive of 21
Trailing P/E10.4×12.8×8th cheapest of 20
ROE the price implies10.8%10.0%10th most demanding of 21
ROE delivered19.3%16.3%9th highest of 21
Bond spread99 bp104 bp4th tightest of 8

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
Globe Life GLUnited States$11.7B0%+6%19%1.78×10.8%19.3%
Unum UNMUnited States$11.8B-9%-4%2%1.11×7.0%2.2%
Aditya Birla Capital ABCAPITAL.NSIndia$12.1B+17%+24%12%2.64×43.5%12.1%
Aegon AGN.ASNetherlands$12.7B+2%+16%10%1.28×8.4%10.5%
CNA Financial CNAUnited States$13.1B+9%+2%10%1.28×7.6%9.6%
Mapfre MAP.MCSpain$13.9B+3%+5%12%1.27×8.6%12.4%
Brookfield Wealth Solutions BNT.TOCanada$14.1B-9%-13%2%0.70×9.5%2.3%
Gjensidige Forsikring GJF.OLNorway$14.2B+7%+7%30%5.79×19.6%29.9%
Suncorp SUN.AXAustralia$14.6B+19%-3%10%2.11×12.0%9.8%
Kinsale Capital KNSLUnited States$8.97B+28%+8%28%4.88×32.7%27.8%
Powszechny Zaklad Ubezpieczen Spolka Akcyjna PZU.WAPoland$15.9B+15%+1%20%1.86×20.1%19.5%
Lincoln National LNCUnited States$8.01B+19%+12%33%0.90×10.1%33.3%
Hiscox HSX.LUnited Kingdom$8.00B+7%+4%17%2.09×15.6%16.6%
ASR Nederland ASRNL.ASNetherlands$17.1B+17%+6%13%1.75×8.4%13.1%
China Taiping Insurance 0966.HKHong Kong$7.77B-19%+19%36%0.59×8.1%36.2%
Axis Capital AXSUnited States$7.68B+6%+10%16%1.34×8.4%16.0%
Great Eastern G07.SISingapore$7.30B+20%+27%15%1.71×11.5%14.8%
Db Insurance 005830.KSSouth Korea$6.96B-2%+14%18%0.89×5.3%18.5%
New China Life Insurance 1336.HKHong Kong$20.1B-26%+44%42%0.77×9.9%42.3%
RLI RLIUnited States$6.55B+36%+6%22%3.86×16.8%22.1%
Legal & General LGEN.LUnited Kingdom$20.9B+10%+137%26%7.60×70.6%26.2%

Globe Life bonds and credit

Globe Life has 4 bonds outstanding with $1.80B face value. The agencies rate it A; its bonds trade like BBB. Weighted yield 5.65%, a spread of 99 bp over government bonds.

Every bond, yield and spread in the cockpit →

Questions

Who are Globe Life's main competitors?
Named competitors: Aflac (AFL), Unum Group (UNM), Primerica (PRI), American Equity Investment Life (AEL.AX), MetLife (MET). The cockpit's measured peer set (industry) also includes Unum (UNM), Aditya Birla Capital (ABCAPITAL.NS), Aegon (AGN.AS), CNA Financial (CNA), Mapfre (MAP.MC), Brookfield Wealth Solutions (BNT.TO).
Is Globe Life expensive compared with its peers?
On price / book it trades at 1.78× against a peer median of 1.52×, 9th most expensive of 21 in its peer set. The share price implies a return on equity of about 10.8%; Globe Life delivers 19.3%, so the price asks less than the business earns today.
How has Globe Life stock performed?
Over six months to 18 Nov 2026 the shares returned +0.5% against +8.0% for the median peer; over one year +18.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.